Community-Based Participatory Research (CBPR) Programs
Gilead Sciences' Community-Based Participatory Research Programs fund community-led, drug-agnostic research to improve HIV and other health outcomes in underserved populations.
Browse similar grants
Funder: Gilead Sciences
Due Dates: October 9, 2026: Letter of Interest (LOI) deadline for CREATE-ACE 2026
Funding Amounts: Typically up to $180,000 per award over two years; 4 awards anticipated per cycle.
Summary: Supports community-based organizations in conducting research to improve health outcomes for populations of need, with a focus on drug-agnostic projects in HIV prevention and treatment.
Description
Gilead Sciences' Community-Based Participatory Research (CBPR) Programs are designed to empower community-based organizations (CBOs) to lead and participate in research projects that address health inequities and improve outcomes for populations of need. The CREATE-ACE 2026 program specifically supports research to enhance engagement in HIV prevention and treatment, targeting community groups in Australia, Canada, and Europe. Projects must be drug-agnostic and focus on innovative approaches to address unmet community needs in therapeutic areas such as HIV, oncology, and liver diseases.
